Windtree Therapeutics (WINT) Misses Q1 EPS by 12c

Windtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.

For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth